JPT Peptide Technologies | GenomeWeb

JPT Peptide Technologies

As part of the deal, the companies will develop peptide-based applications on JPT's high-throughput proteomics screening platform. 

NEW YORK (GenomeWeb News) – JPT Peptide Technologies and The Institute for Medical Immunology at the Charite in Berlin announced on Wednesday an agreement to develop serological peptide biomarkers for the differential diagnosis of chronic fatigue syndrome.

Austrian tools provider Tecan and Berlin-based JPT Peptide Technologies this week announced that they will promote each other's products.

NEW YORK (GenomeWeb News) – Tecan and JPT Peptide Technologies today announced a deal to co-promote JPT's catalog peptide arrays and profiling capabilities.

Arrayjet recently installed a customized version of its Ultra Marathon microarrayer instrument at JPT Technologies.

The Dutch array vendor is working closely with partners in the pharmaceutical industry and academia to optimize internally developed kinase-screening assays for use in drug discovery and as companion diagnostics.

Kinexus President Steven Pelech told BioArray News recently that the new kinase-inhibitor screening service will complement the firm's menu of Kinex antibody and reverse lysate microarrays.

The $6.8 million deal will provide TheraCode with peptide-based services as well as high-content peptide arrays, peptide tools, and peptide libraries.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.